From: Adiponectin gene polymorphisms and risk of type 2 diabetes: an updated evidence for meta-analysis
Subgroup | Number of studies | OR (95% CI) | Z-value | P-value | Test of heterogeneity | |
---|---|---|---|---|---|---|
I2 (%) | P | |||||
TT genotype | 20 | 0.87 (0.77, 0.98) | 1.84 | 0.026 | 38 | 0.05 |
Ethnicity | ||||||
Asian | 9 | 0.90 (0.75, 1.08) | − 1.07 | 0.28 | 0.00 | 0.56 |
European | 9 | 0.80 (0.67, 0.97) | − 1.58 | 0.023 | 60 | 0.01 |
American | 2 | 0.98 (0.72, 1.33) | − 0.29 | 0.92 | 60.3 | 0.11 |
Study design | ||||||
Case–control | 14 | 0.87 (0.70, 1.08) | − 1.22 | 0.22 | 52 | 0.012 |
Cohort | 6 | 0.80 (0.64, 1) | − 1.93 | 0.05 | 0.00 | 0.71 |
Sex | ||||||
Male | 19 | 0.78 (0.65, 1.03) | − 0.98 | 0.69 | 65 | 0.04 |
Female | 19 | 0.82 (0.75, 1.21) | − 0.75 | 0.61 | 75 | 0.02 |
GT genotype | 20 | 0.79 (0.60, 1.02) | − 1.77 | 0.07 | 93.8 | < 0.001 |
Ethnicity | ||||||
Asian | 9 | 0.99 (0.71, 1.3) | − 0.032 | 0.97 | 90.3 | < 0.001 |
European | 9 | 0.67 (0.42, 1.06) | − 1.70 | 0.08 | 95.3 | < 0.001 |
American | 2 | 0.61 (0.20, 1.81) | − 0.89 | 0.37 | 97.2 | < 0.001 |
Study design | ||||||
Case–control | 14 | 0.79 (0.59, 1.05) | − 1.5 | 0.11 | 93 | < 0.001 |
Cohort | 6 | 0.79 (0.43, 1.45) | − 0.75 | 0.45 | 95.9 | < 0.001 |
Sex | ||||||
Male | 19 | 0.76 (0.45, 1.93) | − 1.02 | 0.76 | 92 | < 0.001 |
Female | 19 | 0.64 (0.37, 1.78) | − 0.96 | 0. 45 | 95 | < 0.001 |
GG genotype | 21 | 0.76 (0.56, 1.04) | -1.6 | 0.09 | 96.7 | < 0.001 |
Ethnicity | ||||||
Asian | 10 | 1.04 (0.71, 1.24) | 0.23 | 0.81 | 95.7 | < 0.001 |
European | 9 | 0.57 (0.30, 1.06) | − 1.75 | 0.08 | 97.5 | < 0.001 |
American | 2 | 0.58 (0.24, 1.40) | − 1.20 | 0.22 | 96.4 | < 0.001 |
Study design | ||||||
Case–control | 15 | 0.75 (0.52, 1.06) | − 1.59 | 0.11 | 96.3 | < 0.001 |
Cohort | 6 | 0.80 (0.38, 1.68) | − 0.56 | 0.57 | 97.7 | < 0.001 |
Sex | ||||||
Male | 20 | 0.85 (0.62, 1.75) | − 0.76 | 0.43 | 90 | < 0.001 |
Female | 20 | 0.77 (0.34, 1.32) | − 1.61 | 0.21 | 85.4 | < 0.001 |